ARKG Investment Tracker

Source from:official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·05-10 07:13
      ARKG Investment Tracker position change: Decreased position in CareDx by 44,291 shares, the number of shares held decreased 2.37% compared to the previous period and now represents 3.41% of the total position.
      75Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·05-10 07:13
      ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 1,375 shares, the number of shares held decreased 0.079% compared to the previous period and now represents 8.89% of the total position.
      43Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·05-10 07:13
      ARKG Investment Tracker position change: Increased position in Tempus AI by 23,283 shares, the number of shares held increased 1.18% compared to the previous period and now represents 8.61% of the total position.
      86Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·05-10 07:13
      ARKG Investment Tracker position change: Decreased position in Veracyte by 14,238 shares, the number of shares held decreased 1.53% compared to the previous period and now represents 3.25% of the total position.
      104Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·05-10 07:13
      ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 33,134 shares, the number of shares held decreased 1.68% compared to the previous period and now represents 2.49% of the total position.
      1.30KComment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·05-09 07:13
      ARKG Investment Tracker position change: Increased position in Prime Medicine, Inc. by 17,868 shares, the number of shares held increased 0.39% compared to the previous period and now represents 1.33% of the total position.
      27Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·05-09 07:13
      ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 39,774 shares, the number of shares held increased 0.39% compared to the previous period and now represents 1.48% of the total position.
      7.97K2
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·05-09 07:13
      ARKG Investment Tracker position change: Increased position in GeneDx Holdings by 1,659 shares, the number of shares held increased 0.39% compared to the previous period and now represents 1.26% of the total position.
      171Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·05-09 07:13
      ARKG Investment Tracker position change: Increased position in BioNTech SE by 459 shares, the number of shares held increased 0.39% compared to the previous period and now represents 0.96% of the total position.
      47Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·05-09 07:13
      ARKG Investment Tracker position change: Increased position in Generate Biomedicines by 1,824 shares, the number of shares held increased 0.39% compared to the previous period and now represents 0.61% of the total position.
      41Comment
      Report
       
       
       
       

      Most Discussed